STOCK TITAN

SCYNEXIS (SCYX) director receives new RSU and stock option grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

SCYNEXIS INC director Brian Philippe Tinmouth received new equity awards. On June 26, 2026, he was granted 2,875 shares of Common Stock as a restricted stock unit award, with all shares vesting on the first anniversary of the grant if he continues serving as a non-employee director.

He was also granted a stock option for 2,875 shares of Common Stock at an exercise price of $3.85 per share, expiring on June 25, 2036, which likewise vests in full after one year of continued service. Following the grant, he directly holds 12,125 shares of Common Stock. The share amounts reflect a 1-for-8 reverse stock split effective on May 29, 2026.

Positive

  • None.

Negative

  • None.
Insider Tinmouth Brian Philippe
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 2,875 $0.00 --
Grant/Award Common Stock 2,875 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 2,875 shares (Direct, null); Common Stock — 12,125 shares (Direct, null)
Footnotes (1)
  1. One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. On May 29, 2026, the common stock of the Issuer underwent a 1-for-8 reverse stock split (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split. One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.
RSU grant size 2,875 shares Restricted stock units granted on June 26, 2026
Stock option grant size 2,875 shares Option covering Common Stock granted on June 26, 2026
Option exercise price $3.85/share Stock Option (Right to Buy) for Common Stock
Option expiration June 25, 2036 Expiration date of director stock option
Common shares held after 12,125 shares Director’s direct Common Stock holdings following grants
Reverse split ratio 1-for-8 Reverse stock split effective May 29, 2026
RSU vesting 100% after 1 year Cliff vesting on first anniversary of grant
Option vesting 100% after 1 year Cliff vesting on first anniversary of grant
restricted stock unit financial
"One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) ... underlying security title Common Stock"
reverse stock split financial
"the common stock of the Issuer underwent a 1-for-8 reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
non-employee director financial
"provided that the non-employee director is providing continuous services on the applicable vesting date"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tinmouth Brian Philippe

(Last)(First)(Middle)
1 EVERTRUST PLAZA
13TH FLOOR

(Street)
JERSEY CITY NEW JERSEY 07302-6548

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
SCYNEXIS INC [ SCYX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/26/2026A2,875(1)A$0.0012,125(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$3.8506/26/2026A2,875 (3)06/25/2036Common Stock2,875$0.002,875D
Explanation of Responses:
1. One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.
2. On May 29, 2026, the common stock of the Issuer underwent a 1-for-8 reverse stock split (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split.
3. One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.
/s/ Robert F. Joyce Jr., by Power of Attorney06/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did SCYNEXIS (SCYX) director Brian Tinmouth receive in this Form 4?

Director Brian Philippe Tinmouth received equity-based compensation from SCYNEXIS. He was granted 2,875 restricted stock units and a stock option for 2,875 shares, both vesting after one year of continued service as a non-employee director.

How many SCYNEXIS shares were granted to the director on June 26, 2026?

He was granted 2,875 restricted stock units and a stock option covering 2,875 shares. These awards are part of his director compensation and are subject to a one-year cliff vesting requirement tied to continued board service.

What is the exercise price and expiration date of the new SCYNEXIS stock option?

The stock option granted to the director has an exercise price of $3.85 per share and expires on June 25, 2036. All 2,875 option shares vest together on the first anniversary of the grant date if service continues.

When do the SCYNEXIS restricted stock units granted to the director vest?

All 2,875 restricted stock units vest 100% on the first anniversary of the grant date. Vesting requires that the non-employee director continues providing services to SCYNEXIS through that one-year vesting date without interruption.

How many SCYNEXIS common shares does the director hold after these grants?

After the equity awards reported, the director directly holds 12,125 shares of SCYNEXIS common stock. This figure reflects the company’s 1-for-8 reverse stock split that occurred on May 29, 2026 and adjusted all reported share amounts.

How did SCYNEXIS’ 1-for-8 reverse stock split affect this Form 4?

The 1-for-8 reverse stock split on May 29, 2026 reduced outstanding shares while proportionally adjusting holdings and awards. All share amounts in this Form 4, including the 2,875-unit RSU and 2,875-share option grants, are already shown on a post-split basis.